All In MedTech

Device Trial Radar · NCT06997003

Evaluation of a New Laser Refractive Vision Correction Using the TENEO™ 317 Model 2

Evaluation of a New Customized Corneal Treatment for Laser Refractive Vision Correction Using the TENEO™ 317 Model 2

Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

81

Planned (sponsor's estimate)

Start

Jun 16, 2025

Primary completion

May 2027

Study completion May 2027

Sponsor

Lead sponsor
Bausch & Lomb GmbHNot on our public-company list
Sponsor type
Industry
First posted
May 30, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective, post market clinical follow up study with a three months postoperative follow up to evaluate the visual and refractive outcomes of OCTAVIUS treatment when used as intended.

Conditions

  • Hyperopia and Myopia

Interventions

  • Anterior treatment modeDevice

    Laser-in-situ-Keratomileusis (LASIK) surgery using OCTAVIUS treatment

  • Anterior treatment modeDevice

    Laser-in-situ-Keratomileusis (LASIK) surgery using OCTAVIUS treatment

  • Total treatment modeDevice

    Laser-in-situ-Keratomileusis (LASIK) surgery using OCTAVIUS treatment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of eyes that achieve a Uncorrected Distance Visual Acuity of 20/40 or betterTime frame: Assessed for approximately 90 days

3 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Site 01

    Zlín, Czech Republic, Czechia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.